In the News
CBS News (29 Mar 2023)
FDA approves overdose-reversing Narcan for over-the-counter sale Comments on how OTC naloxone isn’t enough to address issues with access.
Jonathan JK Stoltman, PhD
Jonathan JK Stoltman, PhD is Director of the Opioid Policy Institute. They have been an addiction scientist since 2013. Their work has appeared in leading academic journals and in the media.
In the News
Wired (16 Nov 2022)
Telehealth Sites Put Addiction Patient Data at Risk Our Report 2 covering privacy issues with mHealth addiction websites served as the foundation for this reporting.
In the News
University of Wisconsin Center for Journalism Ethics (5 Dec 2022)
For the media, an urgent call to improve coverage of addiction and recovery Our conversation with Zehra Topbas from the University of Wisconsin Center for Journalism Ethics about the importance of Reporting on Addiction.
Digital Health
Report 2
In the News
WGVU/NPR 🔊(29 Aug 2022)
About the Opioid Policy Institute We talk with Shelley Irwin about Reporting on Addiction and addiction science. 🔊10min listen
In the News
100 Days in Appalachia (14 June 2022)
The Federal Website That’s Supposed to Help ‘Find Treatment’ Needs Work, Experts Say Provided thoughts on findtreatment.gov and how to improve this vital national resource.
In the News
KFF/CNN/USA Today (11 May 2022)
America's response to addiction relies on fixing this website Provided thoughts on findtreatment.gov and how to improve this vital resource.
In the News
WVPB/NPR West Virginia (7 April 2022)
Even After Death, Stories Of Recovery Can Give Hope About the power of narratives when talking about addiction.
In the News
Buzzfeed News (20 Feb 2022)
Here’s What the Overdose Death Trial of Major League Baseball Pitcher Tyler Skaggs Missed About America’s Opioid Crisis Provided thoughts on the inadequacy of criminal justice approaches to addiction.
In the News
Vox/Recode (12 July 2021)
The struggle to make health apps truly private Why privacy and patient advocates are worried that substance use disorder apps aren’t keeping data private.
In the News
TechCrunch (7 July 2021)
Opioid addiction treatment apps found sharing sensitive data with third parties Widely used apps are accessing unique device identifiers that can track users.
In the News
Financial Times (7 July 2021)
Opioid addiction apps access personal data, study finds Platforms gain entry to sensitive user information such as phone number and IP address.